{
    "organizations": [],
    "uuid": "24f593f96027c8b5435e95c621071c295ba6cb29",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-genomedx-biosciences-announces-res/brief-genomedx-biosciences-announces-research-collaboration-with-janssen-pharmaceuticals-to-evaluate-decipher-classifier-decipher-grid-for-drug-development-idUSFWN1SF0PT",
    "ord_in_thread": 0,
    "title": "BRIEF-Genomedx Biosciences Announces Research Collaboration With Janssen Pharmaceuticals To Evaluate Decipher Classifier, Decipher Grid For Drug Development",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Johnson & Johnson:\n* GENOMEDX BIOSCIENCES ANNOUNCES RESEARCH COLLABORATION WITH JANSSEN PHARMACEUTICALS TO EVALUATE THE DECIPHER® CLASSIFIER AND DECIPHER GRID® FOR DRUG DEVELOPMENT\n* GENOMEDX BIOSCIENCES - UNDER DEAL, CO WILL TEST SAMPLES USING ITS GENOME-WIDE EXPRESSION ASSAY FROM MULTIPLE JANSSEN PROSTATE CANCER CLINICAL TRIALS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T19:25:00.000+03:00",
    "crawled": "2018-05-09T12:25:58.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "johnson",
        "johnson",
        "genomedx",
        "bioscience",
        "announces",
        "research",
        "collaboration",
        "janssen",
        "pharmaceutical",
        "evaluate",
        "classifier",
        "decipher",
        "drug",
        "development",
        "genomedx",
        "bioscience",
        "deal",
        "co",
        "test",
        "sample",
        "using",
        "expression",
        "assay",
        "multiple",
        "janssen",
        "prostate",
        "cancer",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}